Science 37 retweeted
Replying to @Science37x
@Science37x @medableinc @THREADresearch leading the way in DCTs, and @MassiveBio serves as direct to patient engine to activate these great #digitalhealth tools! #AI #clinicaltrials #CancerResearch
Decentralized Clinical Trials will not only improve the care of individual patients but include more patients in #clinicaltrials that can benefit them! 🎗️
Check out Dr. Arturo Loaiza-Bonilla's full discussion: bit.ly/3brYi8U
Science 37 retweeted
Replying to @Science37x
@Science37x's new site model speeds up enrollment times for clinical studies by helping sponsors virtually reach a wider range of patients. ow.ly/vJzV50JjPrX
Science 37 retweeted
Because of geographic and access barriers, traditional #ClinicalTrials may exclude more than 90 percent of possible patients and providers. @Science37x shares how its programming allows for greater recruitment diversity and improved data quality. bit.ly/3OH8nOo
Science 37 retweeted
Decentralized #ClinicalTrials made their mark during #COVID19, and researchers now must determine how to carry these agile models into the future. @Science37x shares the importance of choosing the right platform for a unifying experience. bit.ly/3O2gUeA
Science 37 retweeted
With nearly 1,500 wearables studies in 2020, biosensors and digital endpoints are becoming a standard component of #clinicaltrials. physIQ is excited for our collaboration with @Science37x that will deliver on the potential of faster&better clinical trials
bit.ly/32UOHnn
Science 37 retweeted
"From a trustworthy standpoint, I can't say it enough: what we're really seeking here is the human connection point." Ryan Brown, @Science37x #RealChemRHE
Science 37 retweeted
A publicly traded clinical research and testing company, @Science37x, will be moving its headquarters to Morrisville, creating some 250 new jobs in the next several years. #CNSSummit Executive Patron. ow.ly/a1cS50Hm1LY
Science 37 retweeted
#TBT to our last #EconDev announcement for 2021 - @Science37x, Agile Clinical Trial Operating System pioneers, will relocate its HQ from California to @TheRTP. The company will create 250 jobs in @WakeGOV with a $1.5 million investment in @Morrisville_NC.
nccommerce.com/news/press-re…
Science 37 retweeted
🎙️The latest episode of the PC #Podcast is available! We're joined by David Coman, CEO of @Science37x, a decentralized #clinicaltrials platform company, who discusses his organization’s recent public debut via the #SPAC route & more.
➡️bit.ly/326OfSv
#Pharma #NewEpisode
Science 37 retweeted
Specialized networks from @Science37x recently helped bring a flexible, quick, and effective solution to a sponsor aiming to diversify its patient population. Read the case study, sharing how the methods exceeded the study's goals: bit.ly/3215ynQ
Science 37 retweeted
Be sure to catch @SteveSteinhubl moderating a panel of experts at the #CNSSummit2021. The session begins at 2pm ET today!
@Science37x
@SyneosHealth
@JanssenUS
Science 37 retweeted
David Coman of @Science37x speaks on decentralized clinical trials at the #CNSSummit: “The goal is to make it as easy as possible for the patient and accelerate research as fast as possible, that way everyone wins.”
Science 37 retweeted
#CNSSummit Executive Patron, @Science37x partners with 2 CROs in Japan as part of decentralized trials push. ow.ly/ClEK50GBiJW
Science 37 retweeted
The #COVID19 pandemic has had a major impact on #ClinicalTrials around the world, but continuity is key to an effective study. @Science37x considers how its #technology can help researchers better serve patients and collect data. bit.ly/3pYb6tc
Science 37 retweeted
Industry-veteran Elisa Cascade Joins #CNSSummit Executive Patron, @Science37x as Chief Product Officer; Chris Ceppi appointed Chief Technology Officer. ow.ly/sh8550GyL9Y
Science 37 retweeted
Replying to @Science37x
@Science37x Global Health Shares 3 Ways Decentralized Clinical Trials Can Expand Diversity & Improve Participation Rates bit.ly/3C2NIxN #hlth21 #digitalhealth #clinicaltrials #diversity
Science 37 retweeted
.@Science37x is expanding access for patients and providers, anywhere, through agile clinical trials.
$SNCE is enabling universal access to clinical research and helping to accelerate the development of treatments that impact patient lives.
Science 37 retweeted

Josh Wolfe@wolfejosh12 Oct 2021
🇺🇸
United StatesConnected via United States App StoreAccount-level information, not a live location or per-post device.
GREAT explanation from @Science37x $SNCE CEO David Coman of what they are doing to flip clinical trials on their head.
The future like so much else is DISTRIBUTED
Led for Lux family by @AGoulburn
Science 37 retweeted
Technology for the future of clinical trials, today. 🧪
@Science37x’s Operating System supports today’s more agile clinical trial designs by enabling universal access to clinical research and accelerating the development of treatments impacting the future of patient’s lives.
Science 37 retweeted
✨ @Science37x is developing products to help make the world a better place.
$SNCE is enabling universal access to clinical research, making it easier for patients & providers to participate and help accelerate the development of treatments that impact patient lives. 🔬






















